Mumbai, India

Milind Vinayak Sathe, Sr

This inventor holds 1 USPTO granted patent. Top assignee: Unichem Laboratories Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Milind Vinayak Sathe, Sr. Retrieved from https://idiyas.com/inventor/milind-vinayak-sathe-sr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Milind Vinayak Sathe, Sr: Innovator in Pharmaceutical Composition

Introduction

Milind Vinayak Sathe, Sr. is a notable inventor based in Mumbai, Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable and bioequivalent compositions of apixaban.

Latest Patents

Milind Vinayak Sathe, Sr. holds a patent for a pharmaceutical composition of apixaban. This patent describes a stable, reproducible formulation that includes apixaban with a D-particle size of more than 100 microns, preferably between 300 and 1000 microns, and more specifically between 350 and 800 microns. The composition also contains one or more pharmaceutically acceptable excipients. Additionally, the patent outlines a process for preparing this pharmaceutical composition through wet granulation.

Career Highlights

Milind is currently associated with Unichem Laboratories Limited, where he applies his expertise in pharmaceutical development. His work focuses on creating innovative solutions that enhance the efficacy and stability of pharmaceutical products.

Collaborations

Milind has collaborated with several professionals in his field, including Dhananjay Govind Sathe and Srikant V Pimple. These collaborations have contributed to the advancement of pharmaceutical research and development.

Conclusion

Milind Vinayak Sathe, Sr. is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the industry significantly. His innovative approach to apixaban formulations showcases his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…